Table:
begin	end	state
1	11	non-cytoplasmic
12	40	transmembrane
41	51	cytoplasmic
52	74	transmembrane
75	97	non-cytoplasmic
98	120	transmembrane
121	139	cytoplasmic
140	165	transmembrane
166	173	non-cytoplasmic
174	196	transmembrane
197	235	cytoplasmic
236	254	transmembrane
255	259	non-cytoplasmic
260	279	transmembrane
280	296	cytoplasmic
297	317	transmembrane
318	332	non-cytoplasmic
333	359	transmembrane
360	370	cytoplasmic
371	390	transmembrane
391	419	non-cytoplasmic
420	442	transmembrane
443	449	cytoplasmic

Input:
>HSERO_RS13470
MSPLTLGVLYGVVTIVVMCSGMPIAFALGVVATGFMYFFMPESSLDTITQNVYEEIASIT
LLSIPLFILKGAAIGKSPAGKDLYSAIHAWLNKVPGGLGIANVFACALFAAMAGSSPATC
SAIGSAGIPEMRRRGYSPGFAAGIIAAGGTLGILLPPSITMILYAVAAEQSLGRLFLAGI
GPGVLLVLLFAGYAVYRARKEYRLAHAVYSAGGAKSAYLDDEHFTLAQKVEMLPRVLPFL
ILLIGVMVALYGGLATPSETAGLGALLALVLIAVVYRIYKPREIAPFLSSTIKESGMLLL
IIGMSLLYSYVMSYLHISQSAAQWVVDLHLSKWLLLAVILGMVIVLGFFLPPVSIILMTA
PIILPPLKAAGFDLIWFGIVMTVVMEMGLIHPPVGLNLFVIKNIAPDIALGDVIKGTIPF
LALMFLAVLLLCMFPGIATLLPDLLMGAK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server